Page last updated: 2024-09-04

olmesartan and morphine

olmesartan has been researched along with morphine in 3 studies

Compound Research Comparison

Studies (olmesartan)	Trials (olmesartan)	Recent Studies (post-2010) (olmesartan)	Studies (morphine)	Trials (morphine)	Recent Studies (post-2010) (morphine)
841	185	554	44,270	5,200	8,695

Protein Interaction Comparison

Protein	Taxonomy	morphine (IC50)
Delta-type opioid receptor	Mus musculus (house mouse)	0.2939
Delta-type opioid receptor	Rattus norvegicus (Norway rat)	0.2278
Kappa-type opioid receptor	Mus musculus (house mouse)	0.0828
Mu-type opioid receptor	Rattus norvegicus (Norway rat)	0.0385
Kappa-type opioid receptor	Rattus norvegicus (Norway rat)	0.0545
Mu-type opioid receptor	Homo sapiens (human)	0.122
Delta-type opioid receptor	Homo sapiens (human)	0.1199
Kappa-type opioid receptor	Cavia porcellus (domestic guinea pig)	0.9308
Kappa-type opioid receptor	Homo sapiens (human)	0.655
Mu-type opioid receptor	Mus musculus (house mouse)	0.3305
Mu-type opioid receptor	Cavia porcellus (domestic guinea pig)	0.202
Beta-2 adrenergic receptor	Cavia porcellus (domestic guinea pig)	0.25

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andricopulo, AD; Moda, TL; Montanari, CA	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Amin, EA; Dosa, PI	1

Reviews

1 review(s) available for olmesartan and morphine

Article	Year
Tactical Approaches to Interconverting GPCR Agonists and Antagonists. Journal of medicinal chemistry, 2016, Feb-11, Volume: 59, Issue:3 Topics: Animals; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, G-Protein-Coupled; Structure-Activity Relationship	2016

Other Studies

2 other study(ies) available for olmesartan and morphine

Article	Year
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012

Article

Year

Hologram QSAR model for the prediction of human oral bioavailability.

Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007

Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.

Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012